Real demand
It replaces folk-remedy hangover cures with a research-backed ingredient and a repeatable purchase; the founder says repeat purchases have stayed above 40% of revenue since the reformulation, indicating people keep paying.
Real-revenue cases
A New York founder turned a Japanese hangover-remedy ingredient (DHM) into a US supplement brand, reaching $1M in sales in about 10 months and now running near $200K/month through subscriptions and retail.
01
It replaces folk-remedy hangover cures with a research-backed ingredient and a repeatable purchase; the founder says repeat purchases have stayed above 40% of revenue since the reformulation, indicating people keep paying.
Customers buy the hangover pill and electrolyte concentrate directly; online revenue leans on subscriptions/memberships, with additional sales through retail chains like Urban Outfitters, Anthropologie and American Eagle.
Folk hangover cures such as hair of the dog or a bacon-egg-cheese sandwich.
02
A $100 Facebook ad test targeting alcohol-purchase behaviors drove 300-400 visitors to a Shopify landing page and collected 30+ email signups; the official launch went out on Product Hunt.
03
The cold-start loop here — cheap ad test, landing-page signups, then trading early traction for supplier trust — maps directly onto AI apps: test signup intent with a small ad or community post, then use early user data to negotiate API credits or cloud resources.
04
Revenue basis · Founder self-reported, unaudited (see source page)
The $200K/month, $1M in 10 months and $2.5M annual target are founder self-reported and unaudited.
The 40% repeat-purchase revenue, 35% gross margin and $11.7K starting cost come from the Starter Story page with no stated methodology.
No breakdown of subscription vs. retail revenue, and no CAC or retention data.